Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Prevention and treatment of skeletal disorder with EP2 receptor subtype selective prostaglandin E2 agonists

Prevention and treatment of skeletal disorder with EP2 receptor subtype selective prostaglandin E2 agonists

US Patent 6426359 · Granted Jul 30, 2002

Estimated economic value: $677,937,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists2025
BCKDK inhibitors and/or degraders2025
Gaming system with wireless charging system and method of determining wireless c2025
Gaming machine2025
DKK1 antibodies and methods of use2025
System and method for mounting a topper screen to a gaming machine cabinet2025
Gaming system with wireless charging system and method of determining wireless c2024
Anti-sclerostin antibodies and their use to treat bone disorders as part of a re2023
Gaming machine2023
Lighting display assembly for a gaming machine2022
Gaming system with wireless charging system and method of determining wireless c2022
Gaming machine2022